Evidence map›Paper›PMID 41612291›Full record

ArticleBMC health services research2026

Multilevel barriers and facilitators to smoking cessation among men living with HIV in Vietnam: a qualitative study of male patients and healthcare providers.

Thanh Ha-Lan Hoang, Claire V T Nguyen, Gloria Guevara Alvarez, Trang Nguyen, Nam Nguyen, Louise Adermark, Nawi Ng, Donna Shelley, Mari Armstrong-Hough

Registry-linked trialAbstract read
In one paragraph

Article in BMC health services research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05162911 (Implementing Tobacco Use Treatment in HIV Clinics in Vietnam), which is not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05162911 nacompletednot on this map

Implementing Tobacco Use Treatment in HIV Clinics in Vietnam

TypeinterventionalSponsorNew York UniversityRan2021 to 2026Enrolled672ConditionsTobacco UseArmsAsk, advise, Assist and refer to the Quitline, Ask, advise, Assist and referral to onsite counselor, Ask, advise, Assist and referral to onsite counselor and NRT
3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Thanh Ha-Lan HoangSchool of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. thanh.hoang@gu.se.
Claire V T NguyenNew York University School of Global Public Health, New York, NY, USA.
Gloria Guevara AlvarezNew York University School of Global Public Health, New York, NY, USA.
Trang NguyenInstitute of Social and Medical Studies, Hanoi, Vietnam.
Nam NguyenInstitute of Social and Medical Studies, Hanoi, Vietnam.
Louise AdermarkDepartment of Pharmacology, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Nawi NgSchool of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Donna ShelleyNew York University School of Global Public Health, New York, NY, USA.
Mari Armstrong-HoughNew York University School of Global Public Health, New York, NY, USA.

Funding

Implementing Tobacco Use Treatment in HIV Clinics In Viet NamR01CA240481 · NCI · NEW YORK UNIVERSITY · PI NGUYEN, NAM TRUONG, SHELLEY, DONNA R · 2020 to 2024
$3.3M
NCI NIH HHS R01 CA240481
6 · The paper itself

Abstract

backgroundIn Vietnam, tobacco smoking is highly prevalent among people living with HIV. However, research on engaging this population in tobacco use treatment is limited. To fill this gap, we aimed to identify barriers and facilitators to smoking cessation and examine implications for the design and implementation of tobacco use treatment for people living with HIV in Vietnam.

methodsWe conducted in-depth interviews with 24 patients and 13 healthcare providers at three HIV outpatient clinics in Hanoi to explore barriers to and facilitators of smoking cessation at the patient-, provider-, and system levels. We conducted an abductive thematic analysis guided by the Theoretical Domains Framework.

resultsPatient-level barriers to smoking cessation included patients’ perception that smoking is not an immediate threat to their health and does not impact HIV outcomes, lack of familiarity with cessation aids, stress, emotional distress, nicotine dependence, exposure to environments in which smoking is common, and social norms that promote male smoking and link smoking to masculinity. Patients and providers also described having “determination” to quit as an important precursor for making a quit attempt. Providers reported barriers to offering treatment, including lack of skills, knowledge, and competing demands related to treating tobacco use. However, they embraced their role in helping patients quit and described trusting relationships with patients as a potential facilitator of engaging smokers in cessation treatment. At the system level, both patients and providers identified easy access and affordability of tobacco products as barriers to cessation.

conclusionThis study identified opportunities for increasing engagement in tobacco use treatment at the patient, provider, and system levels. Provider training to deliver treatment, patient education about the health implications of continuing to smoke, system changes that support the integration of treatment into routine care, and revision of tobacco taxation are needed.

trial registrationClinicalTrials.gov NCT05162911. Registered on December 16, 2021.

Indexed as

Health PersonnelHIV InfectionsSmoking CessationAdultHealth Knowledge, Attitudes, PracticeHealth Services AccessibilityHumansInterviews as TopicMaleMiddle AgedQualitative ResearchTobacco Use DisorderVietnamBarriers and facilitatorsHIVImplementation scienceSmoking cessationTobacco use treatment

Identifiers

PMID41612291
PMCPMC12937535

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.